Zhaoping Li, MD, the chief of the Division of Clinical Nutrition at UCLA Health and director of the UCLA Center for Human Nutrition in Los Angeles, also welcomed the news
Wegovy Vision Loss Lawsuit Overview According to legal documents, patients allege that Novo Nordisk, the manufacturer of Wegovy, knew the drug might increase a persons risk of developing serious eye injuries such as nonarteritic anterior ischemic optic neuropathy (NAION) and failed to adequately warn consumers
As clinical evidence supporting GLP-1 medications for weight loss continues to mount, and as federal policy discussions around obesity treatment expand, more states are reconsidering whether Medicaid should cover weight loss drugs
At present, the available evidence suggests that both GLP-1 agonist and SGLT2 inhibitors produce unfavourable outcomes, and should be avoided in pregnancy and during lactation